Sign in

CIK 0001937653

  • Non-accelerated filer
  • Smaller reporting company

Zymeworks Inc.

Sign in to watch
Ticker
ZYME
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
883099146
Phone
+1 302-274-8744
Business address
108 PATRIOT DRIVE, SUITE A, MIDDLETOWN, DE, 19709
Former names
Zymeworks Delaware Inc.
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Open-market sale Chief Scientific Officer sold 9,560 shares at $22.67 ($216,759)
  5. 4 Open-market sale Chair & CEO sold 30,424 shares at $22.67 ($689,819)
  6. 4 Grant or award EVP, Chief Bus & Fin Officer acquired 459 shares (grant or award)
  7. 4 Open-market sale EVP & Chief Medical Officer sold 10,538 shares at $25.10 ($264,471)
  8. 4 Open-market sale Chair & CEO sold 54,343 shares at $25.10 ($1,363,841)
  9. 4 Open-market sale Chief Scientific Officer sold 20,110 shares at $25.10 ($504,699)
  10. 4 Open-market sale Chair & CEO sold 47,528 shares at $27.02 ($1,284,311)
  11. 4 Grant or award Director acquired 415,000 shares (grant or award)
  12. 4 Derivatives Options or other derivatives
  13. 3 Insider Initial Statement of Ownership
  14. 3 Insider Initial Statement of Ownership
  15. 4 Shares withheld for taxes Director gave up 41 shares (to pay taxes)
  16. 4 Open-market buy Director bought 55,421 shares at an average $11.47 ($635,586)
  17. 4 Open-market buy Director bought 128,713 shares at an average $11.32 ($1,456,408)
  18. 4 Open-market buy Director bought 317,208 shares at an average $11.42 ($3,623,970)
  19. 4 Open-market buy Director bought 127,415 shares at an average $11.75 ($1,497,322)
  20. 4 Open-market buy Director bought 97,349 shares at an average $12.61 ($1,227,309)

Page 2 of 6 · 120 filings